CSBR:NASDAQ
Champions Oncology Inc
$4.75
arrow_downward
-1.86%(-0.090) 1D
Nov 10, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.82
High
$4.88
Low
$4.75
Mkt. cap
66.11M
Avg. vol.
9.19K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.82
High
$4.88
Low
$4.75
Mkt. cap
66.11M
Avg. vol.
9.19K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
FXStreet
·
19 minutes ago
S&P 500: Higher yields weigh on equities – Deutsche Bank
Business Insider
·
11 minutes ago
3 Reasons a Top Stock Strategist Sees a Big Year-End Rally for S&P 500
The Motley Fool
·
10 minutes ago
Why the S&P 500 Could Be Heading for a Repeat of 2018
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com